RT Journal Article
SR Electronic
T1 Stroke Risk Prediction from Medical Survey Data: AI-Driven Risk Analysis with Insightful Feature Importance using Explainable AI (XAI)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.17.23298646
DO 10.1101/2023.11.17.23298646
A1 Akter, Simon Bin
A1 Akter, Sumya
A1 Pias, Tanmoy Sarkar
YR 2024
UL http://medrxiv.org/content/early/2024/06/11/2023.11.17.23298646.abstract
AB Prioritizing dataset dependability, model performance, and interoperability is a compelling demand for improving stroke risk prediction from medical surveys using AI in healthcare. These collective efforts are required to enhance the field of stroke risk assessment and demonstrate the transformational potential of AI in healthcare. This novel study leverages the CDC’s recently published 2022 BRFSS dataset to explore AI-based stroke risk prediction. Numerous substantial and notable contributions have been established from this study. To start with, the dataset’s dependability is improved through a unique RF-based imputation technique that overcomes the challenges of missing data. In order to identify the most promising models, six different AI models are meticulously evaluated including DT, RF, GNB, RusBoost, AdaBoost, and CNN. The study combines top-performing models such as GNB, RF, and RusBoost using fusion approaches such as soft voting, hard voting, and stacking to demonstrate the combined prediction performance. The stacking model demonstrated superior performance, achieving an F1 score of 88%. The work also employs Explainable AI (XAI) approaches to highlight the subtle contributions of important dataset features, improving model interpretability. The comprehensive approach to stroke risk prediction employed in this study enhanced dataset reliability, model performance, and interpretability, demonstrating AI’s fundamental impact in healthcare.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe Behavioural Risk Factor Surveillance System (BRFSS)2022 dataset was used in this study, https://www.cdc.gov/brfss/index.html